Former boxing champion Floyd Mayweather has teamed up with Magnum Nutraceuticals to launch a new supplement brand, ONE OF ONE (101).
The active nutrition-focused brand has created a seven-strong range of supplements, including pre-workouts, hydration solutions, creatine monohydrate, a peptide builder and other protein-based products.
It is primarily catered to the active consumer market aged between 25–50, though Bill believes that the range could appeal to a wide range of demographics, including longevity-focused older individuals, younger athletes and those looking for natural weight management solutions.
Moving into the supplement space
The supplement industry is highly lucrative, and many celebrities are now making their move into the scene — with huge names such as David Beckham and Kourtney Kardashian debuting their brands in 2024. (See more about how celebrities have impacted the nutraceutical industry in our previous article HERE)
Floyd began his journey into the supplement industry over two years ago, when he partnered with Magnum Nutraceuticals to create 101, and since then they have developed a seven-strong range of supplements, comprised of 18 SKUs, for the sports nutrition market.
“Throughout my career, I’ve been all about discipline and preparation; I never cut corners and I always push to be the best, and that’s exactly why I created ONE OF ONE,” notes Mayweather.
“I wanted to bring a brand that reflects my mindset, something people can trust that delivers real results with no excuses. In a world full of quick fixes, I’m offering a better way—just pure, high-quality performance.”
“There’s a lot of brands out there making big claims, we had to make sure ONE OF ONE is built different. We’re not about false hype or fillers, we’re focused on creating clean, effective products that deliver real results.”
“This isn’t just another supplement line,” he states, “it’s the only one I trust with my name on it, because I want to provide a range that helps people to perform at their highest level — that’s what sets us apart.”
The product line
When formulating their supplement line, Floyd and the team at Magnum aimed to create a premium range packed with patented and branded, scientifically-backed ingredients that could offer support to the modern active consumer or athlete.
To achieve this, 101 has created a product line which target wellness from a range of angles, including:
- Boosting muscle mass and building strength: With its ‘Peptide Builder’ and ‘Whey Protein Powder’ formulations, consumers can fuel lean muscle growth. The whey-based solution also contains digestive enzymes which can reduce bloating and support digestion.
- Achieving hydration: The ‘Hydration’ formulation which is filled with pure electrolytes and taurine, is designed to fight cramps and reduce fatigue
- Speeding up muscle recovery: Containing the branded fava bean protein ingredient PeptiStrong, the Peptide Builder is designed for those partaking in intensive exercise, and has been proven to stimulate protein synthesis four times more than whey protein, while also offering up to a 103% recovery in strength post-exercise. This solution also contains dileucine, a bioavailable form of the key amino acid involved in muscle protein synthesis.
- Targeting gut health and digestion: Through the Greens and Gut Health solution, consumers can get their fix of spirulina-derived prebiotic fibres, vitamins and minerals, boosting digestive and overall wellness.
- Enhancing cognition: 101’s Sport and Loaded Pre-Workout solutions contain citruline, caffeine, L-carnitine electrolytes and NeuroRush, a patented coffee extract ingredient that improves memory and focus — which can all help users to feel fresh during their workout.
Future directions: catering to the weight management market
During the past five years, there has been a sharp rise in prescriptions for GLP-1 receptor agonists, which can be administered to patients suffering from obesity or type 2 diabetes.
The public interest in weight management has also soared, with many that cannot obtain a prescription for drugs like Ozempic and Wegovy turning to natural solutions that can offer similar effects.
As there is a significant overlap between the needs and wants of demographics looking to manage their weight and those who are training for fitness, Bill notes that 101 will be catering to this market in the future: “We’re definitely focused on weight management at the moment, and we’ve got some research going on right now in the weight management, support and loss categories.”
“Consumers on GLP-1 drugs will need to modify their diet to see long-term success. They should definitely increase their protein intake, though this isn’t always easy for everybody, so it’s currently an industry challenge.”
Because of this trend, Bill believes that “it’s up to the industry to try and educate people and give them supplementsthe supplement that can help them on their weight management journey.”
“We’ve got a couple of products that we’re looking to develop as fast-follows in Q1 and 2 of 2025, which will follow our initial launch,” he concludes.
[Image credit: Instagram, @youare_1of1]